Johns Hopkins Medicine

Alzheimer's Disease Research Center

Anti-Amyloid Treatment in Asymptomatic Alzheimer's

Principal Investigator: Paul Rosenberg, M.D.

The goal of this clinical trial is to determine if treatment with a medication that alters amyloid accumulation in the brain can delay progression to mild cognitive impairment among cognitively normal individuals with imaging evidence of amyloid accumulation.

For more information, contact Samantha Horn at 410-550-9020 or e-mail